Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2025, 7(2); doi: 10.25236/FMSR.2025.070211.

Modulation of Osteogenic Differentiation in Human Dental Pulp Stem Cells by EphrinB2 Signaling

Author(s)

Songjun Li, Xu Zhou, Cuiyan Ye

Corresponding Author:
Songjun Li
Affiliation(s)

Department of Dentistry, Longgang E.N.T. Hospital & Shenzhen Key Laboratory of E.N.T., Institute of E.N.T., Shenzhen, Guangdong, China, 518172

Abstract

Current treatments for dental pulp diseases, such as root canal therapy, fail to regenerate functional pulp tissue, highlighting the need for innovative regenerative strategies. Human dental pulp stem cells (hDPSCs) hold significant potential for pulp regeneration due to their multipotency, but the molecular pathways governing their differentiation remain poorly understood. This study investigates the role of EphrinB2 signaling in regulating osteogenic differentiation of hDPSCs and identifies EphB4 as its key mediator. Using lentiviral overexpression of EphrinB2 combined with a periodontal ligament stem cell-derived decellularized extracellular matrix (PDLSC-DECM) scaffold, we demonstrated that EphrinB2 significantly enhances early osteogenic differentiation, as evidenced by upregulated expression of RUNX2, BMP2, and IGF, alongside increased alkaline phosphatase (ALP) activity. Strikingly, inhibition of EphB4 (via TNYL-RAW peptide) suppressed osteogenesis, whereas EphB2 inhibition had no effect, indicating EphB4-specific regulation. Notably, late-stage mineralization markers (OCN, DSPP, DMP1) remained unaffected, suggesting EphrinB2-EphB4 signaling primarily drives early osteogenic commitment. These findings contrast with reports in other cell types where EphB2 dominates, underscoring cell type-specific receptor usage. Our work establishes EphrinB2-EphB4 as a critical axis for hDPSC osteogenesis and provides a scaffold-integrated strategy to advance dental pulp regeneration. This study lays the foundation for EphrinB2-targeted therapies to overcome the limitations of conventional dental treatments and promote functional tissue repair.

Keywords

Osteogenic Differentiation, EphrinB2 Signaling, Human Dental Pulp Stem Cells (hDPSCs), Periodontal Ligament Stem Cells (PDLSC), Extracellular Matrix (DECM)

Cite This Paper

Songjun Li, Xu Zhou, Cuiyan Ye. Modulation of Osteogenic Differentiation in Human Dental Pulp Stem Cells by EphrinB2 Signaling. Frontiers in Medical Science Research(2025), Vol. 7, Issue 2: 73-82. https://doi.org/10.25236/FMSR.2025.070211.

References

[1] Arifin, F.A., et al., Comparison of oral health-related quality of life among endodontic patients with irreversible pulpitis and pulp necrosis using the oral health-related endodontic patient's quality of life scale. Odontology, 2024.

[2] Dahake, P.T. and S. Kothari, Microbiological Profile of Primary Teeth with Irreversible Pulpitis and Pulp Necrosis with/without Abscess and their Susceptibility to Three Antibiotics as Intracanal Medication. Int J Clin Pediatr Dent, 2023. 16(2): p. 312-320.

[3] Kokkas, A.B., et al., Irreversible but not reversible pulpitis is associated with up-regulation of tumour necrosis factor-alpha gene expression in human pulp. Int Endod J, 2007. 40(3): p. 198-203.

[4] Weitz, D., et al., Preoperative Factors Associated with Anesthesia Failure for Patients Undergoing Nonsurgical Root Canal Therapy: A National Dental Practice-Based Research Network Study. J Endod, 2021. 47(12): p. 1875-1882.

[5] Alqahtani, Q., et al., Decellularized Swine Dental Pulp Tissue for Regenerative Root Canal Therapy. J Dent Res, 2018. 97(13): p. 1460-1467.

[6] Stefanska, K., et al., Dental pulp stem cells - A basic research and future application in regenerative medicine. Biomed Pharmacother, 2024. 178: p. 116990.

[7] Nakashima, M. and H. Tanaka, Pulp Regenerative Therapy Using Autologous Dental Pulp Stem Cells in a Mature Tooth with Apical Periodontitis: A Case Report. J Endod, 2024. 50(2): p. 189-195.

[8] Alshawkani, H.A., et al., Regenerative Potential of Dental Pulp Stem Cells in Response to a Bioceramic Dental Sealer and Photobiomodulation: An In Vitro Study. J Contemp Dent Pract, 2024. 25(4): p. 313-319.

[9] Hardin, L.T., et al., Cigarette smoking exposure disrupts the regenerative potential of dental pulp stem cells. Tob Induc Dis, 2023. 21: p. 101.

[10] Yu, H., et al., Tensile force promotes osteogenic differentiation via ephrinB2-EphB4 signaling pathway in orthodontic tooth movement. BMC Oral Health, 2025. 25(1): p. 118.

[11] Fu, Y., et al., Imbalanced EphB4/EphrinB2 Signaling Modulates Bone Resorption in Periodontitis Induced by Porphyromonas gingivalis. ACS Infect Dis, 2024. 10(4): p. 1152-1161.

[12] Zhou, J., et al., Low-intensity pulsed ultrasound regulates osteoblast-osteoclast crosstalk via EphrinB2/EphB4 signaling for orthodontic alveolar bone remodeling. Front Bioeng Biotechnol, 2023. 11: p. 1192720.

[13] Zhu, S., et al., Bidirectional ephrinB2‑EphB4 signaling regulates the osteogenic differentiation of canine periodontal ligament stem cells. Int J Mol Med, 2020. 45(3): p. 897-909.

[14] Decaris, M.L., et al., Transferable cell-secreted extracellular matrices enhance osteogenic differentiation. Acta Biomater, 2012. 8(2): p. 744-52.

[15] Decaris, M.L., et al., Cell-derived matrix coatings for polymeric scaffolds. Tissue Eng Part A, 2012. 18(19-20): p. 2148-57.

[16] Fan, W.B., J.N. Zhao, and N.R. Bao, [Effects of bidirectional EphB4-EphrinB2 signaling on bone remodeling]. Zhongguo Gu Shang, 2013. 26(8): p. 705-8.

[17] Wang, W., et al., EphrinB2 overexpression enhances osteogenic differentiation of dental pulp stem cells partially through ephrinB2-mediated reverse signaling. Stem Cell Res Ther, 2020. 11(1): p. 40.

[18] Agarwal, K. and R. Lamprecht, EphB2 activation in neural stem cells in the basolateral amygdala facilitates neurogenesis and enhances long-term memory. Cell Mol Life Sci, 2024. 81(1): p. 277.

[19] Heng, B.C., et al., EphrinB2 signaling enhances osteogenic/odontogenic differentiation of human dental pulp stem cells. Arch Oral Biol, 2018. 87: p. 62-71.

[20] Morales, A., et al., Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells. Lab Invest, 2021. 101(7): p. 921-934.

[21] Liu, Y.L., et al., Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer. Cancers (Basel), 2019. 11(12).

[22] Zhao, C., et al., Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab, 2006. 4(2): p. 111-21.